Immediate Impact
2 from Science/Nature 63 standout
Citing Papers
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
Works of Kate Oliver being referenced
Phase 1, Open-Label, Dose Escalation Study of I-131-CLR1404 (CLR 131) in Patients with Relapsed or Refractory Multiple Myeloma
2019
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Kate Oliver | 87 | 118 | 33 | 106 | 25 | 295 | |
| Jitka Hausnerová | 68 | 131 | 33 | 74 | 35 | 265 | |
| M K Heatley | 81 | 59 | 30 | 70 | 17 | 249 | |
| Imre Pete | 77 | 110 | 26 | 86 | 21 | 254 | |
| Moito Iijima | 74 | 146 | 41 | 84 | 18 | 300 | |
| Daniela Trog | 77 | 108 | 52 | 44 | 21 | 334 | |
| Valerie Heong | 129 | 100 | 30 | 68 | 25 | 229 | |
| Sayaka Ueno | 81 | 79 | 60 | 95 | 28 | 297 | |
| Ouping Huang | 33 | 149 | 23 | 110 | 26 | 308 | |
| Weihua Lou | 120 | 100 | 37 | 45 | 23 | 320 | |
| Eduardo Paulino | 83 | 70 | 23 | 57 | 33 | 275 |
All Works
Login with ORCID to disown or claim papers
Loading papers...